Ledger.Open graph →
SEC Form D · filed September 14, 2015

IMPEL NEUROPHARMA INC

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

John D. Hoekman · Seattle, WAExec · DirectorStewart D. Parker · Seattle, WADirectorMichael P. Hite · Seattle, WAExec · DirectorBrian D. Zelickson · Minneapolis, MNExec · DirectorPhilip Warth · San Clemente, CADirectorHGI Opportunity Select Fund V Managing Co., LLC · Norfolk, VAExec · DirectorJohn Corpus · Denver, COExec · DirectorHGI US Property Fund IX Managing Co., LLC · Norfolk, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗